Cancer-Drug Maker Nabs $80M Financing, Names New CEO
San Diego-based precision oncology company TP Therapeutics, which makes drugs aimed at addressing treatment resistance, said Friday that it completed an $80 million round of mezzanine financing led by life sciences...To view the full article, register now.
Already a subscriber? Click here to view full article